Recent NMPA updates streamline API approvals and enforce stricter environmental/GMP compliance.
Major Changes
- ICH Harmonization: Adoption of Q12 for lifecycle management.
- Green Regulations: Mandatory eco-assessments for new plants.
- Associated Review: Faster API-drug linkage approvals.
- Inspection Intensification: Risk-based overseas audits.
These reforms elevate China's API sector globally.